Abstract
Introduction
When the disease caused by the human immunodeficiency virus (HIV) is left untreated, it generally progresses inexorably in all infected persons, from asymptomatic infection to the condition of complete destruction of the immune system, resulting in acquired immunodeficiency syndrome (AIDS) [1] . However, today, thanks to antiretroviral therapy (ART), HIV infection has become a chronic condition that can be successfully managed long-term [2] [3] [4] . Some observational studies have suggested that persons infected with HIV can live nearly as long as non-infected persons [5, 6] . Owing to the prolonged life expectancy of persons infected with HIV, there has been an increase in the chronic diseases and complications associated with the treatment of HIV and the drugs used to manage HIV diseases, including acute and/or chronic renal disease [7] . In HIV-infected persons, kidney damage may occur as a result of the direct effects of the virus, such as HIV-associated nephropathy (HIVAN), as well as the indirect effects of HIV, including complications of immunodeficiency caused by HIV, secondary (oppor-tunistic) infections and side effects from the treatment of these conditions, i.e., nephrotoxic drugs. Chronic renal failure is associated with common risk factors, such as age, hypertension and diabetes, but also with certain antiretroviral drugs (tenofovir, indinavir and others) [8] .
Epidemiology of Renal Failure in Persons Infected with HIV
Croatia, with an annual rate of new HIV diagnoses of 10-20/1,000,000 inhabitants, is among the countries with the lowest prevalence rates. According to the HIV/ AIDS Registry of the Croatian National Institute of Public Health, from 1985, when the first cases of HIV infection were recorded in Croatia, to the end of 2014, a total of 1,194 HIV-positive individuals have been registered. Possible factors responsible for an increased risk of developing acute/chronic renal failure (ARF/CRF) are advanced age, female sex, diabetes, hypertension, intravenous drug abuse, certain coinfections (hepatitis B virus, hepatitis C virus), low CD4 T-lymphocyte count, the use of some antiretroviral drugs, a history of renal impairment and high HIV viral load. Numerous studies have already demonstrated that the use of antiretroviral drugs and suppression of the viral load can improve kidney function and reduce proteinuria, thereby indicating that HIV has a nephrotoxic effect. This is particularly evident in AfroAmericans, for whom the risk for CRF is nearly three times higher than for Caucasians [9] .
In a large study involving over 35,000 patients, 0.4% of them developed stage 4 or 5 renal failure (GFR <30 ml/min or dialysis or transplant), with an incidence rate of 0.67/1,000 person years of follow-up (PYFU) [8] . In a cross-sectional multicenter EuroSIDA survey, the prevalence of end-stage renal disease (ESRD) was 0.5% [10] , and an observational cohort study conducted in Great Britain showed a 3.8-fold increase in ESRD among the black HIV-positive patients in the cohort during the 12-year study period [11] . The percentage of patients infected with HIV in dialysis centers around the world ranges from 0.3% to as high as 38% [12] . From 1985 to 1999 the percentage of dialysis centers providing care to HIV-positive patients in the United States increased from 11% to 39% [13] .
Methods for Treating Chronic Renal Failure in HIV-infected Patients
For HIV-infected patients who develop severe renal impairment, whether acute or chronic, replacement of renal function is necessary. They can be treated with hemodialysis (HD), peritoneal dialysis (PD), and may be candidates for kidney transplantation [12] [13] [14] . In the aforementioned EuroSIDA survey, out of 122 patients with ESRD, 96 received dialysis and 26 renal transplant. The most frequent causes of ESRD were HIV-associated nephropathy and other glomerulonephritis [10] . The advantages and disadvantages of each form of dialysis in HIV-infected patients are presented in Table 1 . Additional shortcomings of PD are the loss of protein into the dialysate in already asthenic patients, cognitive motor dysfunction in advanced HIV diseases and reduced patient compliance [14, 15] . Priority should be given to HD and transplantation when possible. The observational cohort study conducted in Great Britain showed that the 5-year survival of patients infected with HIV who had received transplants was similar to that of patients infected with HIV who were receiving dialysis and on the transplant list (85% and 89%, respectively). The good transplant results of this group of patients should be placed in the context of a young patient population, relatively short period of monitoring and, most importantly, the exclusion of patients with contraindications for transplantation, among whom survival is significantly limited. Patients infected with HIV have a markedly higher rate of kidney rejection in the first posttransplant year in comparison to transplant patients not infected with HIV: 31-48% vs. 12-24%, probably associated with HIV-modulated immune response and less exposure to immunosuppressants, together with highly active antiretroviral therapy [11] .
Prevention of HIV Transmission in Dialysis Centers
Healthcare personnel should be aware of the risk of occupational exposure to blood-borne pathogens in their daily duties. Therefore, they should be expected to fully comply with the standard precautions to prevent exposure to blood, other bodily fluids and tissues potentially containing HIV and other blood-borne pathogens [16, 17] . Administration of dialysis to patients infected with HIV increases the risk of sharps injuries, particularly needlesticks. The risk of seroconversion after a needlestick involving exposure to the blood of a HIV-positive patient is 0.3%, while the risks for hepatitis B and C are considerably higher, 2% for HCV and 6-30% for HBV [16, [18] [19] [20] . HIV, like HBV and HCV, does not pass through intact skin and the airborne transmission of this virus has not been confirmed. Contacts via broken skin, blood splashes on the mucous membranes and other forms of mucocutaneous incidents rarely result in seroconversion and infection [16] . In a retrospective study by Cardo et al. [19] , the risk factors increasing the transmission of HIV infection after percutaneous exposure were deep injury, injury with a device that was visibly contaminated with blood, injury with a device that had previously been placed in the source patient's vein and the death of the source patient two months after the percutaneous incident. These factors are probably surrogate markers of viral inoculum. Although low titer viremia may mean lower inoculum, it does not entirely exclude the possibility of the transmission of HIV infection because the viral load does not include the intracellular HIV. Transmission of HIV infection from source patients with undetectable HIV levels in the blood has been documented [20] . The first case of the transmission of HIV infection from a patient to a healthcare worker occurred in 1984 [21] . In 1987, the US Centers for Disease Control and Prevention (CDC) issued Recommendations for Prevention of HIV Transmission in Healthcare Settings and for other bloodborne pathogens, in which the concept of universal precautions was introduced [22] . According to these recommendations, the blood and bodily fluids of every patient are potentially infectious and should be treated as such. The CDC recommends compliance with the recommendations for control and prevention of blood-borne infections issued by the United States Occupational Safety and Health Administration (OSHA). These recommendations are regularly updated and revised according to information from recent studies and are readily available in printed or electronic form via the CDC website [22, 23] . From 1984 to 1999, 57 healthcare workers in the United States acquired HIV infection occupationally, most often from needlestick incidents (84%). From 1999 to the end of 2013, owing to compliance with the CDC recommendations, only one healthcare worker acquired HIV infection occupationally (a laboratory technician from a needle puncture while working with a live HIV culture) [24] . In dialysis units, there have been no reported cases of the transmission of HIV among patients in the United States but cases were reported in Argentina (two dialysis centers), Columbia and Egypt [25] . Postexposure prophylaxis (PEP) significantly reduces the risk of infection and is, therefore, justified whenever possible [19, 20, 26] .
Experiences of Other Countries in the Management of Kidney Failure in Persons Infected with HIV
The international guidelines are largely based on the recommendations of the CDC, with certain particularities related to the dialysis centers, equipment and type of dialyzer. The European Best Practice Guidelines for the Prevention and Management of HBV, HCV and HIV in Hemodialysis Patients recommend the suitable implementation of the standard precautions for protection from the transmission of infectious agents, which has achieved a very low risk of infection transmission. It is necessary to screen for the presence of individual pathogens (HBV, HCV and HIV) in all patients included in a dialysis program for the first time or when are transferred from other dialysis centers, having obtained the patients' prior informed consent. The isolation of patients infected with HIV in a separate area and the use of special dialysis machines for them are not recommended. The principles for the prevention of the transmission of HBV infection are also sufficient for the prevention of the transmission of HIV [27] . The most common errors in the protocol for infection control that can lead to the transmission of infection are the reuse of dialyzers, blood lines and the same needles for different patients; the use of contaminated multidose heparin vials and the use of ineffective disinfectant (benzalkonium chloride) [28] . The recommendations of the Infectious Diseases Society of America state that dialysis is safe for healthcare workers and patients if the recommendations of the CDC for the prevention and control of infection are strictly followed. Vascular access for dialysis (the placement of endovenous catheters and the creation of arteriovenous fistulae) should be provided for all patients, including those infected with HIV [29] . On the other hand, in some countries, such as the Republic of South Africa, in addition to the implementation of the standard precautions and annual screening for the causes of infectious diseases in all dialysis patients, it is recommended that patients infected with HIV should be dialyzed in separate areas or rooms, although it is not insisted on the use of dedicated machines [30] . The majority of patients would like to receive the recommended therapy.
Croatian Recommendations for the Dialysis of HIV-Positive Patients
The recommendations should be applied to the majority of patients.
The guidelines can be the basis for the recommended application.
LEVEL 2 We advise
A large number of patients would like to receive the recommended therapy.
Various options can be applied; an individualized approach is required.
The guidelines should be discussed before the recommendations are applied. 
Conclusion
HIV is an important public health problem, which poses challenges to experts and healthcare personnel in cases of renal failure and the management of renal replacement therapy. The majority of these patients are on hemodialysis, while a significantly smaller number are on peritoneal dialysis or have received transplants. Healthcare personnel should be aware of the risk of occupational exposure to blood-borne infection in their daily work, and are expected to comply with all the measures that can prevent their exposure to blood, other bodily fluids and tissues that may contain potentially blood-borne infectious pathogens. The dialysis procedure for HIVpositive patients characterized by the extracorporeal circulation of blood presents a risk for inoculating the virus in the event of a needlestick incident, although the seroconversion risk after needlestick injuries is 0.3%, while the risks of seroconversion for hepatitis B and C are significantly higher: 2% for HCV and as high as 6-30% for HBV. Postexposure prophylaxis with antiretroviral therapy for four weeks significantly lowers the risk of seroconversion even further.
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